Literature DB >> 1739910

High incidence of ras gene mutation in intrahepatic cholangiocarcinoma.

M Tada1, M Omata, M Ohto.   

Abstract

The DNA sequences around codons 12, 13, and 61 of the ras gene were analyzed by polymerase chain reaction and direct sequencing in 18 intrahepatic cholangiocarcinomas. The ras gene mutations were found in 9 of 18 (50%): 6 in K-ras codon 12, 1 in K-ras codon 13, 1 in K-ras codon 61, and 1 in N-ras codon 12. The incidence of mutations was higher in the hilar type of intrahepatic cholangiocarcinomas, especially when these tumors were large. The incidence and spectrum of the mutations were almost the same as those reported in colon cancers, possibly indicating similar etiologic agent(s) in the carcinogenesis of both cancers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739910     DOI: 10.1002/cncr.2820690509

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

2.  Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.

Authors:  Supak Yothaisong; Hasaya Dokduang; Anchalee Techasen; Nisana Namwat; Puangrat Yongvanit; Vajarabhongsa Bhudhisawasdi; Anucha Puapairoj; Gregory J Riggins; Watcharin Loilome
Journal:  Tumour Biol       Date:  2013-07-06

3.  Using 2-step PCR and restriction endonuclease digestion to detect K-ras mutation in paraffin-embedded tissues: is it reliable?

Authors:  W C Su; N H Chow; C H Huang; H S Liu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

4.  Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

Authors:  Minoru Tada; Yousuke Nakai; Takashi Sasaki; Tsuyoshi Hamada; Rie Nagano; Dai Mohri; Koji Miyabayashi; Keisuke Yamamoto; Hirofumi Kogure; Kazumichi Kawakubo; Yukiko Ito; Natsuyo Yamamoto; Naoki Sasahira; Kenji Hirano; Hideaki Ijichi; Keishuke Tateishi; Hiroyuki Isayama; Masao Omata; Kazuhiko Koike
Journal:  World J Clin Oncol       Date:  2011-03-10

5.  Expression of oncogene products HER2/Neu and Ras and fibrosis-related growth factors bFGF, TGF-beta, and PDGF in bile from biliary malignancies and inflammatory disorders.

Authors:  W C Su; S C Shiesh; H S Liu; C Y Chen; N H Chow; X Z Lin
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 6.  Genetic profiling of intrahepatic cholangiocarcinoma.

Authors:  Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Curr Opin Gastroenterol       Date:  2012-05       Impact factor: 3.287

7.  Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.

Authors:  A Tannapfel; L Weinans; F Geissler; A Schütz; A Katalinic; F Köckerling; J Hauss; C Wittekind
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

8.  New insights on cholangiocarcinoma.

Authors:  Manuela Gatto; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2010-03-15

Review 9.  Perioperative Management of Hilar Cholangiocarcinoma.

Authors:  Katherine E Poruk; Timothy M Pawlik; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2015-05-29       Impact factor: 3.452

10.  Enhancement of biliary carcinogenesis in hamsters by cholecystokinin.

Authors:  Y Ikematsu; T Tomioka; Y Tajima; T Tsunoda; T Kanematsu
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.